Crossmark

Pharmaceutically modified subtilisins withstand acidic conditions and effectively degrade gluten in vivo

Published Online: 2019-05-16

Authors

Darwish, Ghassan

Helmerhorst, Eva J.

Schuppan, Detlef

Oppenheim, Frank G.

Wei, Guoxian
License Information

Text and Data Mining valid from 2019-05-16

Version of Record valid from 2019-05-16
More Information

Article History

Received: 16 August 2018

Accepted: 26 April 2019

First Online: 16 May 2019

Competing Interests

: The authors declare no competing interests.

Document is current